Sanofi backs guidance as it reports higher sales
April 27, 2023 at 02:25 AM EDT
The French pharma company confirmed that it expects 2023 business earnings per share--a key metric--to grow low-single digit at constant exchange rates, barring unforeseen major adverse events.
